BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 29880027)

  • 1. A computational tool to detect DNA alterations tailored to formalin-fixed paraffin-embedded samples in cancer clinical sequencing.
    Kato M; Nakamura H; Nagai M; Kubo T; Elzawahry A; Totoki Y; Tanabe Y; Furukawa E; Miyamoto J; Sakamoto H; Matsumoto S; Sunami K; Arai Y; Suzuki Y; Yoshida T; Tsuchihara K; Tamura K; Yamamoto N; Ichikawa H; Kohno T; Shibata T
    Genome Med; 2018 Jun; 10(1):44. PubMed ID: 29880027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted or whole genome sequencing of formalin fixed tissue samples: potential applications in cancer genomics.
    Munchel S; Hoang Y; Zhao Y; Cottrell J; Klotzle B; Godwin AK; Koestler D; Beyerlein P; Fan JB; Bibikova M; Chien J
    Oncotarget; 2015 Sep; 6(28):25943-61. PubMed ID: 26305677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HaloPlex Targeted Resequencing for Mutation Detection in Clinical Formalin-Fixed, Paraffin-Embedded Tumor Samples.
    Moens LN; Falk-Sörqvist E; Ljungström V; Mattsson J; Sundström M; La Fleur L; Mathot L; Micke P; Nilsson M; Botling J
    J Mol Diagn; 2015 Nov; 17(6):729-39. PubMed ID: 26354930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amplicon-Based Targeted Next-Generation Sequencing of Formalin-Fixed, Paraffin-Embedded Tissue.
    Strengman E; Barendrecht-Smouter FAS; de Voijs C; de Vree P; Nijman IJ; de Leng WWJ
    Methods Mol Biol; 2019; 1908():1-17. PubMed ID: 30649717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TumorNext: A comprehensive tumor profiling assay that incorporates high resolution copy number analysis and germline status to improve testing accuracy.
    Gray PN; Vuong H; Tsai P; Lu HM; Mu W; Hsuan V; Hoo J; Shah S; Uyeda L; Fox S; Patel H; Janicek M; Brown S; Dobrea L; Wagman L; Plimack E; Mehra R; Golemis EA; Bilusic M; Zibelman M; Elliott A
    Oncotarget; 2016 Oct; 7(42):68206-68228. PubMed ID: 27626691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [High-throughput sequencing of frozen and paraffin-embedded tumor and normal tissue].
    Kerick M; Timmermann B; Schweiger MR
    Pathologe; 2010 Oct; 31 Suppl 2():255-7. PubMed ID: 20812012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shallow whole genome sequencing for robust copy number profiling of formalin-fixed paraffin-embedded breast cancers.
    Chin SF; Santonja A; Grzelak M; Ahn S; Sammut SJ; Clifford H; Rueda OM; Pugh M; Goldgraben MA; Bardwell HA; Cho EY; Provenzano E; Rojo F; Alba E; Caldas C
    Exp Mol Pathol; 2018 Jun; 104(3):161-169. PubMed ID: 29608913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Copy number analysis by low coverage whole genome sequencing using ultra low-input DNA from formalin-fixed paraffin embedded tumor tissue.
    Kader T; Goode DL; Wong SQ; Connaughton J; Rowley SM; Devereux L; Byrne D; Fox SB; Mir Arnau G; Tothill RW; Campbell IG; Gorringe KL
    Genome Med; 2016 Nov; 8(1):121. PubMed ID: 27846907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Accuracy of Whole-Exome Sequencing with Formalin-Fixed Paraffin-Embedded and Fresh Frozen Tissue Samples.
    Oh E; Choi YL; Kwon MJ; Kim RN; Kim YJ; Song JY; Jung KS; Shin YK
    PLoS One; 2015; 10(12):e0144162. PubMed ID: 26641479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Next-Generation Sequencing Using S1 Nuclease for Poor-Quality Formalin-Fixed, Paraffin-Embedded Tumor Specimens.
    Chun SM; Sung CO; Jeon H; Kim TI; Lee JY; Park H; Kim Y; Kim D; Jang SJ
    J Mol Diagn; 2018 Nov; 20(6):802-811. PubMed ID: 30055350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted high throughput sequencing in clinical cancer settings: formaldehyde fixed-paraffin embedded (FFPE) tumor tissues, input amount and tumor heterogeneity.
    Kerick M; Isau M; Timmermann B; Sültmann H; Herwig R; Krobitsch S; Schaefer G; Verdorfer I; Bartsch G; Klocker H; Lehrach H; Schweiger MR
    BMC Med Genomics; 2011 Sep; 4():68. PubMed ID: 21958464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of OncoPanel: A Targeted Next-Generation Sequencing Assay for the Detection of Somatic Variants in Cancer.
    Garcia EP; Minkovsky A; Jia Y; Ducar MD; Shivdasani P; Gong X; Ligon AH; Sholl LM; Kuo FC; MacConaill LE; Lindeman NI; Dong F
    Arch Pathol Lab Med; 2017 Jun; 141(6):751-758. PubMed ID: 28557599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-Throughput Amplicon-Based Copy Number Detection of 11 Genes in Formalin-Fixed Paraffin-Embedded Ovarian Tumour Samples by MLPA-Seq.
    Kondrashova O; Love CJ; Lunke S; Hsu AL; ; Waring PM; Taylor GR
    PLoS One; 2015; 10(11):e0143006. PubMed ID: 26569395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of quantitative PCR-based assays for detection of gene copy number aberrations in formalin-fixed, paraffin embedded solid tumor samples.
    Mehrotra M; Luthra R; Abraham R; Mishra BM; Virani S; Chen H; Routbort MJ; Patel KP; Medeiros LJ; Singh RR
    Cancer Genet; 2017 Apr; 212-213():24-31. PubMed ID: 28449808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LoLoPicker: detecting low allelic-fraction variants from low-quality cancer samples.
    Carrot-Zhang J; Majewski J
    Oncotarget; 2017 Jun; 8(23):37032-37040. PubMed ID: 28416765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Digital Sorting of Pure Cell Populations Enables Unambiguous Genetic Analysis of Heterogeneous Formalin-Fixed Paraffin-Embedded Tumors by Next Generation Sequencing.
    Bolognesi C; Forcato C; Buson G; Fontana F; Mangano C; Doffini A; Sero V; Lanzellotto R; Signorini G; Calanca A; Sergio M; Romano R; Gianni S; Medoro G; Giorgini G; Morreau H; Barberis M; Corver WE; Manaresi N
    Sci Rep; 2016 Feb; 6():20944. PubMed ID: 26864208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Towards standardization of next-generation sequencing of FFPE samples for clinical oncology: intrinsic obstacles and possible solutions.
    Ivanov M; Laktionov K; Breder V; Chernenko P; Novikova E; Telysheva E; Musienko S; Baranova A; Mileyko V
    J Transl Med; 2017 Jan; 15(1):22. PubMed ID: 28137276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted Next Generation Sequencing as a Reliable Diagnostic Assay for the Detection of Somatic Mutations in Tumours Using Minimal DNA Amounts from Formalin Fixed Paraffin Embedded Material.
    de Leng WW; Gadellaa-van Hooijdonk CG; Barendregt-Smouter FA; Koudijs MJ; Nijman I; Hinrichs JW; Cuppen E; van Lieshout S; Loberg RD; de Jonge M; Voest EE; de Weger RA; Steeghs N; Langenberg MH; Sleijfer S; Willems SM; Lolkema MP
    PLoS One; 2016; 11(2):e0149405. PubMed ID: 26919633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Robustness of Next Generation Sequencing on Older Formalin-Fixed Paraffin-Embedded Tissue.
    Carrick DM; Mehaffey MG; Sachs MC; Altekruse S; Camalier C; Chuaqui R; Cozen W; Das B; Hernandez BY; Lih CJ; Lynch CF; Makhlouf H; McGregor P; McShane LM; Phillips Rohan J; Walsh WD; Williams PM; Gillanders EM; Mechanic LE; Schully SD
    PLoS One; 2015; 10(7):e0127353. PubMed ID: 26222067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reference Size Matching, Whole-Genome Amplification, and Fluorescent Labeling as a Method for Chromosomal Microarray Analysis of Clinically Actionable Copy Number Alterations in Formalin-Fixed, Paraffin-Embedded Tumor Tissue.
    Gunn SR; Govender S; Sims CL; Khurana A; Koo S; Scoggin J; Moore MW; Cotter PD
    J Mol Diagn; 2018 May; 20(3):279-288. PubMed ID: 29471114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.